规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
---|---|---|---|---|---|---|---|---|---|
0mg | ¥ ƺƮǡȥȥ | > 10 | > 10 | 1 | -- | 1 | -- | ¥ ƺƮǡȥȥ | - + |
1g | ¥ ŽƮǡȥȥ | > 10 | > 10 | -- | 4 | 1 | ¥ ŽƮǡȥȥ | - + | |
g | ¥ ħƙŽǡȥȥ | > 10 | 1 | 1 | 1 | ¥ ħƙŽǡȥȥ | - + | ||
10g | ¥ ƺƺŽǡȥȥ | > 10 | 1 | 1 | 1 | 1 | ¥ ƺƺŽǡȥȥ | - + | |
g | ¥ dždžȥħǡȥȥ | > 10 | -- | 1 | 1 | ¥ dždžȥħǡȥȥ | - + | ||
100g | ¥ ƺȥȥŰǡȥȥ | -- | -- | -- | -- | -- | ¥ ƺȥȥŰǡȥȥ | - + | |
00g | ¥ džŰŰdžȄǡȥȥ | -- | -- | -- | -- | -- | -- | ¥ džŰŰdžȄǡȥȥ | - + |
1000g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
大货 | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
64.
[1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 01 Oct;6:-6.
[]. C Melchiorre, et al. Structure-activity relationships among methoctramine-related polymethylene tetraamines. Chain-length and substituent effects on M- muscarinic receptor blocking activity. J Med Chem. 199 Jan;(1):79-4.
H14
P60-P64-P0-P01+P0+P1-P04+P40-P6-P40-P01
GHS0
7